About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01424891

Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

Lowering LDL cholesterol by statins has been proven to be associated with reduction of proinflammatory regulators e.g. activation of the transcription factor NF-ĸB. Up to now the effects of newer chol...

Lead sponsor: Heidelberg University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Heidelberg University

Age

35 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•35 to 80 years old
•type 2 diabetes
•HbA1c value between 6.0 % and 9.0 %
•elevated LDL-c values \> 100 mg/dl with no lipid lowering treatment within the last six month

Exclusion Criteria

•refused informed consent

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

RECRUITINGPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

Effectiveness of and Implementation Strategies for 'Disfrutando'.

NCT07023406 · Type 2 Diabetes Mellitus (T2DM)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 29, 2011Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateApr 2004

Last updatedAug 29, 2011

Condition

Type 2 Diabetes Inflammation

Locations shown

University Hospital of Heidelberg

Heidelberg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions